Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NuGenerex Diagnostics

NuGenerex Diagnostics?uq=hBqTzBbB
2000 FOUNDED
M&A STATUS
2ndary - Private LATEST DEAL TYPE (Announced)
2 FINANCING ROUNDS
Description

Manufacturer of proprietary infectious disease detection devices. The company's devices include quality, reliable in-vitro diagnostic tests that address the global medical community's needs, enabling physicians with simple, accurate, fast and affordable rapid diagnostic tests for HIV/AIDS, tuberculosis, malaria and other infectious diseases.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Diagnostic Equipment
Parent Company
Primary Office
  • 10102 USA Today Way
  • Miramar, FL 33025
  • United States

+1 (954) 000-0000

NuGenerex Diagnostics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore NuGenerex Diagnostics‘s full profile, request access.

Request full access to PitchBook

NuGenerex Diagnostics Executive Team (2)

Name Title Board
Seat
Contact
Info
Lawrence Salvo Founder, Executive Vice President, Chief Executive Officer and President
Kepa Valencia Director, Research & Development